SpyGlass Pharma, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureOct 1 →Insiders23 insiders bought $221.5M in 17 open-market buys. No sales.→HoldersRa 24.0%Nea 22.1%Sands Capital Alternatives 7.5%→Financing →PeersClosest companies: FDMT, QTTB, BDTX→
From the filings
Figures
- Net income
- −$44.9Mlast 12 months
- Operating cash flow
- −$38.0Mlast 12 months
- Cash and equivalents
- $223.1Mat the last balance sheet
- Shares outstanding
- 33.4M shareson issue